HDGFL2 cryptic proteins report presence of TDP-43 pathology in neurodegenerative diseases

HDGFL2 cryptic proteins report presence of TDP-43 pathology in neurodegenerative diseases

Abstract This letter demonstrates the potential of novel cryptic proteins resulting from TAR DNA-binding protein 43 (TDP-43) dysfunction as markers of TDP-43 pathology in neurodegenerative diseases.

Bibliographic Details
Main Authors:	Anna Calliari, Lillian M. Daughrity, Ellen A. Albagli, Paula Castellanos Otero, Mei Yue, Karen Jansen-West, Naeyma N. Islam, Thomas Caulfield, Bailey Rawlinson, Michael DeTure, Casey Cook, Neill R. Graff-Radford, Gregory S. Day, Bradley F. Boeve, David S. Knopman, Ronald C. Petersen, Keith A. Josephs, Björn Oskarsson, Aaron D. Gitler, Dennis W. Dickson, Tania F. Gendron, Mercedes Prudencio, Michael E. Ward, Yong-Jie Zhang, Leonard Petrucelli
Format:	Article
Language:	English
Published:	BMC 2024-03-01
Series:	Molecular Neurodegeneration
Online Access:	https://doi.org/10.1186/s13024-024-00718-8

Similar Items

TDP-43-regulated cryptic RNAs accumulate in Alzheimer’s disease brains
by: Virginia Estades Ayuso, et al.
Published: (2023-08-01)

Evidence of cerebellar TDP-43 loss of function in FTLD-TDP
by: Sarah Pickles, et al.
Published: (2022-07-01)

Generation and characterization of monoclonal antibodies against pathologically phosphorylated TDP-43.
by: Paula Castellanos Otero, et al.
Published: (2024-01-01)

TDP-43 and other hnRNPs regulate cryptic exon inclusion of a key ALS/FTD risk gene, UNC13A.
by: Yuka Koike, et al.
Published: (2023-03-01)

C-terminal and full length TDP-43 specie differ according to FTLD-TDP lesion type but not genetic mutation
by: Keith A. Josephs, et al.
Published: (2019-07-01)

Cracking the cryptic code in amyotrophic lateral sclerosis and frontotemporal dementia: Towards therapeutic targets and biomarkers
by: Tetsuya Akiyama, et al.
Published: (2022-05-01)

Mechanisms and models of TDP-43 proteinopathies
by: Petrucelli Leonard
Published: (2012-02-01)

TDP-43-associated atrophy in brains with and without frontotemporal lobar degeneration
by: Marina Buciuc, et al.
Published: (2022-01-01)

CRISPR interference to evaluate modifiers of C9ORF72-mediated toxicity in FTD
by: Sarah Pickles, et al.
Published: (2023-08-01)

Allosteric Integrase Inhibitor Influences on HIV-1 Integration and Roles of LEDGF/p75 and HDGFL2 Host Factors
by: Parmit Kumar Singh, et al.
Published: (2022-08-01)

Molecular fragment characteristics and distribution of tangle associated TDP-43 (TATs) and other TDP-43 lesions in Alzheimer’s disease
by: Keith Anthony Josephs, et al.
Published: (2023-12-01)

Altered microRNA expression in frontotemporal lobar degeneration with TDP-43 pathology caused by progranulin mutations
by: Kocerha Jannet, et al.
Published: (2011-10-01)

TDP-1/TDP-43 regulates stress signaling and age-dependent proteotoxicity in Caenorhabditis elegans.
by: Alexandra Vaccaro, et al.
Published: (2012-07-01)

Divergent phenotypes in mutant TDP-43 transgenic mice highlight potential confounds in TDP-43 transgenic modeling.
by: Simon D'Alton, et al.
Published: (2014-01-01)

Three repeat isoforms of tau inhibit assembly of four repeat tau filaments.
by: Stephanie J Adams, et al.
Published: (2010-05-01)

Aberrant deposition of stress granule-resident proteins linked to C9orf72-associated TDP-43 proteinopathy
by: Jeannie Chew, et al.
Published: (2019-02-01)

Novel mutations in TARDBP (TDP-43) in patients with familial amyotrophic lateral sclerosis.
by: Nicola J Rutherford, et al.
Published: (2008-09-01)

The neuropathological diagnosis of Alzheimer’s disease
by: Michael A. DeTure, et al.
Published: (2019-08-01)

White matter damage due to vascular, tau, and TDP-43 pathologies and its relevance to cognition
by: Sheelakumari Raghavan, et al.
Published: (2022-02-01)

TDP-43 maximizes nerve conduction velocity by repressing a cryptic exon for paranodal junction assembly in Schwann cells
by: Kae-Jiun Chang, et al.
Published: (2021-03-01)

TDP-43 regulates LC3ylation in neural tissue through ATG4B cryptic splicing inhibition
by: Torres, P, et al.
Published: (2024)

The pathological phenotypes of human TDP-43 transgenic mouse models are independent of downregulation of mouse Tdp-43.
by: Ya-Fei Xu, et al.
Published: (2013-01-01)

Expression of mutant TDP-43 induces neuronal dysfunction in transgenic mice
by: Dickson Dennis W, et al.
Published: (2011-10-01)

Mutant TDP-43 does not impair mitochondrial bioenergetics in vitro and in vivo
by: Hibiki Kawamata, et al.
Published: (2017-05-01)

Diffuse argyrophilic grain disease with TDP-43 proteinopathy and neuronal intermediate filament inclusion disease: FTLD with mixed tau, TDP-43 and FUS pathologies
by: Shunsuke Koga, et al.
Published: (2023-07-01)

Microglial lysosome dysfunction contributes to white matter pathology and TDP-43 proteinopathy in GRN-associated FTD
by: Yanwei Wu, et al.
Published: (2021-08-01)

Aberrant TDP‐43 phosphorylation: a key wind gap from TDP‐43 to TDP‐43 proteinopathy
by: Zi‐Qi Huang, et al.
Published: (2021-06-01)

Extensive transcriptomic study emphasizes importance of vesicular transport in C9orf72 expansion carriers
by: Dennis W. Dickson, et al.
Published: (2019-10-01)

Publisher Correction to: Diffuse argyrophilic grain disease with TDP-43 proteinopathy and neuronal intermediate filament inclusion disease: FTLD with mixed tau, TDP-43 and FUS pathologies
by: Shunsuke Koga, et al.
Published: (2023-07-01)

DCTN1 Binds to TDP-43 and Regulates TDP-43 Aggregation
by: Manami Deshimaru, et al.
Published: (2021-04-01)

TDP-43 and Limbic-Predominant Age-Related TDP-43 Encephalopathy
by: Lumi Zhang, et al.
Published: (2020-01-01)

The role of tau in neurodegeneration
by: Petrucelli Leonard, et al.
Published: (2009-03-01)

Detection and quantification of novel C-terminal TDP-43 fragments in ALS-TDP
by: Feneberg, E, et al.
Published: (2021)

Nuclear import receptors are recruited by FG-nucleoporins to rescue hallmarks of TDP-43 proteinopathy
by: Bilal Khalil, et al.
Published: (2022-12-01)

LIPIDS ALTERATION IN TDP-43
by: Irene García Toledo, et al.
Published: (2023-10-01)

Tar DNA binding protein-43 (TDP-43) associates with stress granules: analysis of cultured cells and pathological brain tissue.
by: Liqun Liu-Yesucevitz, et al.
Published: (2010-10-01)

Movement disorders are linked to TDP-43 burden in the substantia nigra of FTLD-TDP brain donors
by: Luigi Fiondella, et al.
Published: (2023-04-01)

The cooperative binding of TDP-43 to GU-rich RNA repeats antagonizes TDP-43 aggregation
by: Juan Carlos Rengifo-Gonzalez, et al.
Published: (2021-09-01)

TDP-43: From Alzheimer’s Disease to Limbic-Predominant Age-Related TDP-43 Encephalopathy
by: Wendi Huang, et al.
Published: (2020-02-01)

TDP-43 mislocalization drives neurofilament changes in a novel model of TDP-43 proteinopathy
by: Rachel Atkinson, et al.
Published: (2021-02-01)